Cargando…
The role of DNA methylation in human pancreatic neuroendocrine tumours
Pancreatic neuroendocrine tumours (PNETs) are the second most common pancreatic tumour. However, relatively little is known about their tumourigenic drivers, other than mutations involving the multiple endocrine neoplasia 1 (MEN1), ATRX chromatin remodeler, and death domain-associated protein genes,...
Autores principales: | English, Katherine A, Thakker, Rajesh V, Lines, Kate E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305641/ https://www.ncbi.nlm.nih.gov/pubmed/37434653 http://dx.doi.org/10.1530/EO-23-0003 |
Ejemplares similares
-
OR16-03 Epigenetic Studies Of Pancreatic Neuroendocrine Tumours (PNETs) Reveal Decreased DNA Hydroxymethylation In Non-functioning PNETs But Not Insulinomas
por: English, Katherine A, et al.
Publicado: (2023) -
RF19 | PSUN349 Histone Eraser and Reader Targeting Epigenetic Inhibitors Are Effective in Pancreatic Neuroendocrine Tumours
por: Carmichael, James, et al.
Publicado: (2022) -
A MEN1 pancreatic neuroendocrine tumour mouse model under temporal control
por: Lines, K E, et al.
Publicado: (2017) -
Rare Non-Neuroendocrine Pancreatic Tumours
por: Mormul, Agata, et al.
Publicado: (2023) -
Pasireotide Therapy of Multiple Endocrine Neoplasia Type 1–Associated Neuroendocrine Tumors in Female Mice Deleted for an Men1 Allele Improves Survival and Reduces Tumor Progression
por: Walls, Gerard V., et al.
Publicado: (2016)